Safety analysis of two different regimens of uracil-tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial. [electronic resource]
Producer: 20140918Description: 1253-61 p. digitalISSN:- 1432-0843
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Chemotherapy, Adjuvant
- Colonic Neoplasms -- drug therapy
- Drug Administration Schedule
- Female
- Humans
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Neoplasm Staging
- Risk Factors
- Tegafur -- administration & dosage
- Uracil -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.